GE Healthcare enters Indian pharma sector with FlexFactory platform

 22-May-17, The Hindu Business Line 

GE Healthcare has entered the domestic pharma sector with its biologics, biopharmaceutical targeted, single-use manufacturing platform called FlexFactory with Dr Reddy’s Laboratories as its first customer.

Image: GE Healthcare

So far, the global major has installed the FlexFactory at 23 pharma companies worldwide. The Hyderabad-based Dr Reddy’s will be the first in Asia outside of China and Taiwan. With demand for biopharmaceuticals going up strongly, the biologics-specific product will see robust growth, said Milind Palsule, Country Manager, GE Healthcare Life Sciences.

Cartikeya Reddy, Head of Biologics, Dr Reddy’s, said the FlexFactory platform will enable the company to ramp up capacity and serve more patients in emerging and regulated markets.

 Read the full article 

 Insights